baber/WOPTO huggingface dataset:
Patent GB-1334251-A (GB)
Title: Apparatus for mounting accessories on combine harvesters
IPC: A01F12/40
Filed: 1970-01-13
Abstract: 1334251 Combine harvesters MASSEY FERGUSON SERVICES NV 7 Jan 1971 [13 Jan 1970] 1520/70 Heading A1F Apparatus for mounting an accessory, such as straw chopper 2, on a combine harvester comprises a pair of generally horizontal guide rails 13 on the harvester which receives mounting trunnions secured to the accessory on an axis passing through or close to its centre of gravity so that the accessory can be moved on said rails 13 from an in-use position; Fig. 1, to an intermediate position whereat the accessory can be pivoted about said axis to an out-of-use position, Fig. 5, and vice-versa. To move the accessory from the in-use position to the out-of-use position female fastener parts 8 are released from male fastener parts 7 and the accessory is pushed along rails 13, pivoted about its trunnions. In the out-of-use position the female fastener parts are secured .to further male fastener parts 17. These fasteners, of the toggle action type, are self-centering and a pin 12 and flared recess 11 are provided to assist fixing the accessory in the operational position. The straw chopper 2 (Fig. 7) has a shaft 3 belt-driven by the combine engine and a tubular shaft 3A which carries pivoted blades 20 which co-operate with fixed blades 21 which are adjustably mounted through slots 23 in cutter bars 22. Blades of knives 20 and 21 are double edged so that they can be reversed when one edge is worn.
Patent GB-1336976-A (GB)
Title: Insulating toroidal transformers
IPC: H01F27/32
Filed: 1972-02-17
Abstract: 1336976 Transformers STANDARD TELEPHONES & CABLES Ltd 17 Feb 1972 7316/72 Heading H1T A method of making a toroidal transformer includes placing an inner winding or windings, 1, on a toroidal core, 2, placing insulation in the form of two toroidal channels, 3, over. the inner winding or windings, forming an outer winding or windings 4, and placing insulation in the form of two more toroidal channels, 5, over the whole structure. The core, 2, may be of a ferrite material or may be of a suitable alloy covered with an insulating material. Leads to the windings can emerge through the semas 6 and 7 of the channels, the seam 6, later being sealed with tape. The channels may be blow-moulded from a sheet of a suitable plastics material e.g. nylon, P.V.C. or polyester, and may include an embossed legend and/or cut-outs for retaining a terminal strip. The channels may also include flexible wiring. Electrostatic screening between the windings can be achieved by the provision of a thin electric conductive sheet contained in the inner toroidal insulating channel. In a further embodiment of the invention, one part of each channel is formed with a lip around each edge to provide an overlapping joint between the two channel parts which can then be sealed with an adhesive.
Patent GB-1347465-A (GB)
Title: Apparatus for reproducing graphic material
IPC: B41B27/00
Filed: 1970-09-23
Abstract: 1347465 Colour facsimile IPC SERVICES Ltd 17 Sept 1971 [23 Sept 1970] 45398/70 Heading H4F A scanner for graphic material is controlled by a computer to effect scanning of any desired sub-area of the material, the computer supplying co-ordinate values of successive points to which the scanning light spot is moved to effect this sub-area scan. As shown applied to an arrangement for scanning a transparency 5 and deriving colour outputs from photomultipliers 7 which are processed at 9 to derive magenta, yellow, cyan, and black signals each of which is fed to a photocomposing device for production of a printing image, the computer data controls the position and intensity of the spot on CRT 1 which is focused by objective lens 4 on to the transparency, and dichroic beam-splitters 20 direct red, blue and green light to the photomultipliers 7. Additional photomultipliers 14 are provided to enable modification of the colour density ranges in the processor 9. A photomultiplier 10 monitors the brightness and position of the spot on CRT 1 (a grating and counters may be used to obtain the spot position), and this information is used in 3 to correct the spot characteristics in retroactive manner. Figs. 2 and 3 illustrate the manner in which four separate pictures T1-T4 in the transparency 5 may be scanned to produce a graphic layout as shown in Fig 3, in which the pictures have been masked, scaled and transposed to the areas shown as P1-P4. This is done by providing for the period of each scan line such as Sx, Sy computer data to order the suitable positioning of the spot and its movement in steps of suitable size across the desired picture or part thereof. The output of the apparatus may then be combined with data (e.g. of text to be reproduced) in a manner described in Specification 1,279,296. Schematic circuits for units 3 and 9 are illustrated in Figs. 4 and 5 respectively (not shown).
Patent GB-1347493-A (GB)
Title: Benzazine derivatives
IPC: C07D471/04
Filed: 1971-02-11
Abstract: 1347493 Fused ring heterocycles embodying an amidine structure ASPRO-NICHOLAS Ltd 7 Feb 1972 [11 Feb 1971] 4457/71 Heading C2C The invention comprises compounds of formulµ IIa and IIb: and their acid addition salts and quaternary ammonium derivatives, wherein the atoms shown as having free bonds attached are the 1,2- positions in a quinoline, isoquinoline, phthalazine, quinazoline or quinoxaline ring system or the 3,4-positions in a quinazoline ring system [of which the remaining heterocyclic-ring carbon atom(s) may be substituted by Ph (optionally substituted) or by a fused aromatic carbocyclic ring] and Q is CH 2 CH 2 , CH 2 CH 2 CH 2  or CH : CH, but excluding (i) unsubstituted imidazophthalazine and dihydroimidazophthalazine (IIa); (ii) unsubstituted imidazoquinoline and dihydropyrimidoquinoline (IIb); (iii) dihydroimidazo- (4 - phenyl) isoquinoline, imidazo - (4 - phenyl)- isoquinoline and unsubstituted imidazoisoquinoline (IIa); (iv) dihydroimidazo - (3 - phenyl)quinoxaline, unsubstituted dihydroimidazoquinoxaline and their dihydropyrimido analogues (IIb); (v) 2-unsubstituted imidazoquinazoline and dihydroimidazoquinazoline (IIa); (vi) dihydroimidazo - (2 - phenyl) quinazoline, where the Ph may be substituted, and the dihydropyrimidoquinazoline analogues (IIa). Also described are compounds (I) having the above formulµ, but in which (a) the optionally substituted Ph may be more generally aryl, (b) the polycyclic nucleus and any aryl radical and optionally substituted by radicals which are "pharmaceutically compatible" (as defined in the Specification), and (c) the above exclusions do not apply. Such compounds are prepared (1) when Q is CH 2 CH 2 , by heating together a mono-salt of NH 2 CH 2 CH 2 NH 2  with a strong acid and a quinoline, isoquinoline, phthalazine, quinazoline (not 2-unsubstituted) or 3-substituted quinoxaline, containing a CONH or CSNH structure at the desired points of ring- fusion; (2) when Q is CH : CH, by dehydrogenating a compound in which Q is CH 2 CH 2 ; (3) in the case of dihydroimidazoisoquinolines or dihydropyrimidoisoquinolines, by heating together a mono-salt of NH 2 (CH 2 ) 2-3 NH 2  with a strong acid and an o-phenacylbenzoic acid (or its ester), or with a corresponding isocoumarin; (4) when Q is (CH 2 ) 2-3 , by cyclizing a corresponding chloroalkyl-isoquinoline, -phthalazine or quinazoline; (5) when Q is CH=CH, by cyclizing a corresponding 2,2 - dimethoxyethyl - isoquinoline or phthalazine. Also prepared is 2-bromo-6- chlorophenanthridine. Therapeutic compositions for oral, parenteral or rectal administration comprise compounds (I), as defined above, which have analgesic, antiinflammatory, antibacterial, antiviral and/or cardiovascular activity.
Patent GB-1349896-A (GB)
Title: Optically active coordination complexes containing phosphorus or  arsenic
IPC: C07C233/45
Filed: 1971-05-26
Abstract: 1349896 Optically active complexes containing phosphorus or arsenic MONSANTO CO 26 May 1971 36234/73 Divided out of 1349895 Headings C2J, C2P The invention comprises an optically active co-ordination complex comprising (a) a metal which is rhodium, iridium, ruthenium, osmium, palladium or platinum, and (b) at least one optically active phosphine or arsine ligand (where the terms phosphine and arsine mean PH 3  or AsH 3  or a compound derived therefrom by replacement of one or more hydrogen atoms) wherein the optical activity resides on the phosphorus or arsenic atom and which contains an ortho-substituted phenyl group, the ortho-substituent being OH, C 1-12  alkoxy or aryloxy. The complex may have the formula M<SP>1</SP>(X) n Y<SP>1</SP> or M<SP>2</SP>(X) 2 Y<SP>2</SP> where M<SP>1</SP> is rhodium, iridium, ruthenium or osmium, M<SP>2</SP> is palladium or platinum, X is hydrogen, fluorine, bromine, chlorine or iodine, Y<SP>1</SP> represents (a) 3 monodentate phosphine or arsine ligands, (b) one monodentate and one bidentate ligand or (c) one tridentate ligand, Y<SP>2</SP> represents (a) 2 monodentate phosphine or arsine ligands, or (b) one bidentate ligand and n is 1 or 3. Alternatively, the complex may be a cationic complex containing 2 equivalents of optically active phosphine or arsine ligand per metal atom and a chelating bis-olefin. Those cationic complexes which are solid may be prepared by slurrying an organic complex of rhodium and a chelating bis-olefin in an alcohol, adding the phosphine or arsine and finally a suitable anion such as tetrafluoroborate or tetraphenyl borate. The optically active ligand may have the formula AR<SP>5</SP>R<SP>6</SP>R<SP>7</SP> where A is phosphorus or arsenic and R<SP>6</SP>, R<SP>6</SP> and R<SP>7</SP> are hydrogen; C 1-12  alkyl or alkoxy; alkyl substituted by one or more of NH 2 , COOH, carbonyl, aryl, NO 2  or C 1-4  alkoxy; aryl; aryloxy; phenyl substituted by one or more of alkoxy, alkyl, OH, acetoxy, aryloxy, NH 2  or NO 2  and the number of substituents being less than 3; cycloalkyl having at least 3C; substituted cycloalkyl ; pyrrolyl; thienyl; furyl; pyridyl; piperidyl; or 3-cholesteryl, providing at least one of R<SP>5</SP>, R<SP>6</SP> or R<SP>7</SP> is an o-substituted phenyl group, the substituent being OH, C 1-12  alkoxy or aryloxy. Preferred ligands are methylphenyl - o - anisylphosphine and methylcyclohexyl - o - anisylphosphine. The invention also comprises a solution of a complex of the invention which may be prepared by adding the complex per se to the solvent or by mixing the components in the presence of a solvent.
Patent GC-0000110-A (GC)
Title: Retaining wall block.
Inventor: MACDONALD ROBERT A
IPC: E02D/
Filed: 1999-10-12
Granted: 2005-06-29
Abstract: A retaining wall block has parallel top and bottom faces, a front face, a rear face, first and second side wall faces and a vertical plane of symmetry extending between the front and rear faces. The block is formed as a body portion including the front face, a head portion including the rear face and a neck portion connecting the body portion and the head portion. The body, head and neck portions each extend between the top and bottom faces and between the first and second side wall faces. An opening extends through the neck portion from the top face to the bottom face, dividing the neck portion into first and second neck wall members extending rearwardly from the body portion to the head portion.
Patent ID-26500-A (ID)
Inventor: HANS-JURGEN BEYER
IPC: G06F13/38
Filed: 1998-12-07
Abstract: A communications interface and a data transmission method for the serial transmission of digital data are described, in which at least three signal lines (Tx0, Tx1, Tx2) are provided, which can each have a "high" or a "low" level impressed on them, and a data bit which is to be transmitted can be coded by changing the level of two of the at least three signal lines, and hence as a result of the transition from a first level triplet and to a second level triplet.
Patent ID-25623-A (ID)
Inventor: ARTHUR BRADBURY STEVEN
IPC: B01D45/02
Filed: 1999-01-22
Abstract: A system for providing passive dust control for a transfer of bulk material from a first station to a second station in a material handling system. A dust containment housing encloses a first station and a second station. Bulk material is transferred from the first station to the second station inside the dust containment housing. A region of low pressure inside the dust containment housing is defined by a circulation compartment. Air carrying suspended particles of bulk material flows from a region of high air pressure generated by the transfer of bulk material to the region of low air pressure. The suspended particles of bulk material either remain suspended in the air inside the housing or settle out of the air into the bulk material inside the housing.
Patent ID-26411-A (ID)
Inventor: ANDERSSON THOMAS
IPC: F16L47/02
Filed: 1999-03-05
Abstract: A fusion welding socket (18) for coupling together plastic pipes, is adapted to receive the pipe parts to be coupled together with a tight fit. The diameter of the ends (19) of the socket is greater than the diameter of the socket along an intermediate part (20) and the diameter at the ends is adapted to receive with a tight fit an outer pipe (1) and the diameter of the intermediate part is adapted to receive with a tight fit an inner pipe (2) of a double-pipe conduit which includes two coaxial pipes and a leakage detection space (3) therebetween. The socket includes coils (24-27) having resistance wires or filaments which enable the socket material to be fused locally together with the material in both the outer pipes and the inner pipes of two double-pipe conduits that are to be coupled together with the aid of the socket. The socket also includes at least one passageway (21) which interconnects the spaces in the socket on both sides of the intermediate socket part.
Patent ID-29037-A (ID)
Inventor: INADA SHUJI
IPC: C08G63/183
Filed: 2000-10-18
Abstract: A method of producing a polyester from high-purity bis- beta -hydroxyethyl terephthalate as a raw material containing cations and anions in trace amounts. Polyester production raw materials including bis- beta -hydroxyethyl terephthalate containing cations and anions in a total weight of not more than 50 ppm, ethylene glycol and antimony trioxide and/or germanium dioxide as a polymerization catalyst are heated without substantially distilling off ethylene glycol and then heated under reduced pressure to be polycondensed while ethylene glycol is distilled off.
Patent IL-100611-A (IL)
Title: 4-hydroxy-2, 8-dioxabicyclo [3.2.1] octane-3,4,5-tricarboxylic acid derivatives their preparation and pharmaceutical compositions containing them
IPC: A61P3/06
Filed: 1992-01-08
Abstract: Compounds are described of the formula    <IMAGE>  (I)  wherein R1 represents a hydrogen atom, a hydroxyl group or a group selected from -OCOCH=CHCH(CH3)(CH2)3CH3, -OCOCH=CHC(CH3)=CHCH(CH3)-CH2CH3, or -OCO-X-CH2CH(CH3)CH2CH3 [where X is -CH=CHCH(CH3)-, -CH2CH(OH)CH(CH3)-, -CH=CHC(OH)(CH3)-, -CH2CH(OH)CH2- or -CH2CH2CH(CH3)-)]; R2 represents a hydrogen atom or a hydroxyl group; R3 represents a group selected from -C(=CH2)CH(OR7)CH(CH3)CH2Ph (where R7 is a hydrogen atom or an acetyl group), -C(CH3)=CHCH(CH2R8)CH2Ph (where R8 is a hydrogen or a hydroxyl group), -C(CH2OH)=CHCH(CH3)CH2Ph, -C(=CH2)CH(OH)CH(CH2OH)CH2Ph, -C(=CH2)CH(NHCOCH3)CH(CH3)CH2Ph, -C(CH2NHCOCH3)=CHCH(CH3)CH2Ph or   <IMAGE>    R4, R5 and R6 may each independently represent a hydrogen atom or a methyl group and salts thereof; with the proviso that when either of R1 and R2 represents a hydrogen atom R3 is a group selected from -C(=CH2)CH(OR7)CH(CH3)CH2Ph and -C(CH3)=CHCH(CH3)CH2Ph and when both of R1 and R2 represent hydrogen atoms R3 represents -C(CH3)=CHCH(CH3)CH2Ph. These compounds inhibit the enzyme squalene synthase and/or are intermediates for the preparation of compounds which inhibit the enzyme squalene synthase. Compounds of the invention may be formulated for use in a variety of conditions where a lowering of the level of blood plasma cholesterol in animals would be beneficial and for use in combating fungal infections in animals.
Patent IL-101327-A (IL)
Title: Heterocyclic-cyclic amine derivatives and pharmaceutical compositions containing them
Inventor: VILLALOBOS ANABELLA
IPC: C07D/
Filed: 1992-03-22
Abstract: Compounds of formula (I) wherein R<1>, R<2>, R<7>, R<8>, X, Y, M and L are defined as below. The compounds of formula (I) are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
Patent IL-101896-A (IL)
Title: Diltiazem formulation
IPC: A61K31/55
Filed: 1992-05-17
Abstract: The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles. <IMAGE>   <IMAGE>
Patent IL-108549-A (IL)
Title: Transport system
IPC: G05D1/02
Filed: 1994-02-03
Abstract: PCT No. PCT/GB95/00204 Sec. 371 Date Jul. 29, 1996 Sec. 102(e) Date Jul. 29, 1996 PCT Filed Feb. 1, 1995 PCT Pub. No. WO95/21405 PCT Pub. Date Aug. 10, 1995A transport system which includes a communications network and one or more vehicles each having an on-board control and data exchange unit, wherein the communications network includes a transport control unit; and a plurality of road units arranged in series along a vehicle travel route, each road unit being adapted for communication with the transport control unit so as to exchange data therewith, and being further adapted for direct communication with at least two road units positioned adjacent thereto, wherein the on-board control and data exchange unit includes transceiver apparatus for communicating with each of the plurality of road units in series while traveling therepast; data processing apparatus connected to the transceiver apparatus; and control apparatus, connected to the data processing apparatus for selectably controlling and sensing any of a predetermined plurality of vehicle operating functions in response to signals received by the transceiver apparatus from the road units.
Patent IL-111570-A (IL)
Title: Process for large-scale synthesis of 2', 3'-didehydro-3'-deoxythymidine (d4t) involving the isolation of a d4t n-methylpyrrolidinone solvate and the intermediate d4t nmpo solvate therefor
IPC: C07H19/06
Filed: 1994-11-09
Abstract: An improved process suitable for large-scale production of 2',3'-didehydro-3'-deoxythymidine (d4T) and close analogs is disclosed. The improved process yields d4T in high yield and purity without the use of hazardous reactions or reagents and incorporates several process improvements important on a large scale including a novel purification step involving the isolation of a d4T.N-methylpyrrolidinone solvate.
Patent IL-111922-A (IL)
Title: Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylates their preparation and pharmaceutical compositions containing them
IPC: C07D211/90
Filed: 1994-12-07
Abstract: The present invention relates to the compound rac-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarb oxylate and its pure enantiomers, to processes for the preparation thereof and to the use thereof as pharmaceutical, in particular for treatment of cerebral and neuronal disorders and to an intermediate for the preparation thereof.
Patent IL-112467-A (IL)
Title: Absorbent body and apparatus for its manufacture
IPC: D04H13/00
Filed: 1995-01-27
Abstract: PCT No. PCT/SE95/00185 Sec. 371 Date Aug. 22, 1996 Sec. 102(e) Date Aug. 22, 1996 PCT Filed Feb. 22, 1995 PCT Pub. No. WO95/22952 PCT Pub. Date Aug. 31, 1995An absorbent body and an apparatus for manufacturing an absorbant body having at least two layers of absorbent material, upon each of which a layer of superabsorbent particles has been laid. The particle layers include patterns of through-penetrating openings and one of the particle layers is horizontally displaced in relation to another of the particle layers.
[SE9400642D0]
Patent IL-125559-A (IL)
Title: Anti-inflammatory peptides derived from c-reactive protein and pharmaceutical compositions comprising them
Inventor: FRIDKIN MATITYAHU
IPC: A61K38/08
Filed: 1997-01-27
Abstract: A peptide capable of inhibiting in vitro the enzymatic activity of human leukocyte Elastase (hLE) and/or of human Cathepsin G (hCG), said peptide, which is not the whole C-reactive protein, being selected from: (i) a core peptide corresponding to positions 89-96 of the sequence of human C-reactive protein (CRP) of the formula: Val89-Thr-Val-Ala- Pro-Val-His- Ile96 or a modification thereof characterized by: (ii) substitution of Ile96 by a hydrophobic amino acid residue; (iii) substitution of His95 by D-His or by a residue selected from Asp, Glu, Ser, Thr, Phe and Tyr, and D-forms of the foregoing; (iv) substitution of Val94 by D-Val, or by a residue selected from Ala, His and Phe, and D-forms of the foregoing; (v) substitution of Ala92 by a hydrophobic amino acid residue; (vi) substitution of Val91 by Ala or Gly; (vii) substitution of Thr90 by a residue selected from Asn, Asp, Gln, Glu, Ala, Val and Pro; (viii) substitution of Val89 by a hydrophobic amino acid residue; (ix) a peptide obtained by elongation of a peptide (i) to (viii) at the N- and/or C-terminal; (x) an amide of the C-terminal of a peptide (i) to (ix); and (xi) an N-acyl derivative of a peptide (i) to (x).
Patent IL-126920-A (IL)
Title: Sunrise-dependent timepiece
IPC: G04G9/00
Filed: 1998-11-05
Abstract: An electronic sunrise-dependent timepiece (20), comprising: an oscillator circuit (22) for generating clock pulses at a predetermined frequency, a clock circuit (21) coupled to the oscillator circuit for generating minutes and hours and calendar data, an offset correction circuit (29) coupled to the clock circuit for adding a respective offset derived from a lookup table (30) to the minutes and hours data so as to generate a sunrise-dependent time of day, and a display circuit (27) coupled to the clock circuit for displaying the sunrise- dependent time of day; characterized in that: the offset derived by the offset correction circuit is an incremental offset that is fixedly added to a currently displayed sunrise-dependent time at predetermined adjustment time intervals. 2736 ו' בתשרי התשס" ג - September 12, 2002
Patent IL-142622-A (IL)
Title: Process for the preparation of aminoalcohol derivatives and their further conversion to (1r, 4s)-4- ((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino) -2- cyclopentenyl-1-methanol
IPC: C07D473/02
Filed: 1998-11-26
Abstract: Production of optionally (1S,4R)- or (1R,4S)-1-amino-4-(hydroxymethyl)-2-cyclopentene (VII) or (VIII) (or their salts) involves biotechnological optical resolution of racemic 1-amino-4-(hydroxymethyl)-2-cyclopentene (I) using a hydrolase in presence of an acylating agent. Production of (1S,4R)- or (1R,4S)-1-amino-4-(hydroxymethyl)-2-cyclopentene of formula (VII) or (VIII) (or their salts) involves biotechnological optical resolution of racemic 1-amino-4-(hydroxymethyl)-2-cyclopentene of formula (I) using a hydrolase (specifically a lipase) in presence of an acylating agent.X, Y=H or acyl. Independent claims are included for: (1) preparation of (VII; X, Y= H) or (VIII; X, Y= H) (or their salts) comprising chemical hydrolysis of corresponding compounds in which at least one of X and Y is other than H; and (2) production of (VII; Y= H; X= COR) or (VII; Y= H; X= COR) by (a) reducing 2-azabicyclo-(2.2.1)-hept-5-en-3-one (II) (in racemic or optical isomer form) to racemic (I); (b) carrying out biotechnological optical resolution (I) using a hydrolase in presence of an acylating agent to give (VII; X,Y= H) or (VII; X,Y= H); and (c) acylating to give (VII; Y= H; X= COR) or (VII; Y= H; X= COR). R : 1-4C alkyl, 1-4C alkoxy, aryl or aryloxy. [Image].
Patent IL-147489-A (IL)
Title: Use of docetaxel for preparation of a drug for treating hepatocellular carcinoma
IPC: A61K31/00
Filed: 2002-01-06
Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 muM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.